Management of diarrhea induced by tumors or cancer therapy
- 1 July 1995
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 7 (4) , 325-330
- https://doi.org/10.1097/00001622-199507000-00006
Abstract
Diarrhea is a common event in the clinical history of cancer patients. It can be caused by the presence of tumor or it can be a side effect of treatment. The latter problem is occurring more often because new drugs (CPT-11) or drug combinations (fluorouracil plus interferon or leucovorin) have diarrhea as the dose-limiting toxicity. The clinical use of octreotide, a long-acting somatostatin analogue, seemed to demonstrate an improvement in most diarrheal states induced by tumors (endocrine tumors) or by treatments (short bowel syndrome; chemotherapy-induced diarrhea).Keywords
This publication has 0 references indexed in Scilit: